Clover Health Investments Corp. Class A CLOV

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Clover’s portfolio combines high-choice PPO access and meaningful member benefits with a Clover Assistant-powered care modelWILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its 2027 Medicare Advantage (MA) plan offerings, with a continued focus on PPO choice, affordable

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to the Company’s Board of Directors, effective immediately. The appointments bring together two accomplished leaders whose complementary experience spans public service, Medicare Advantage, clinical practice, healthcare policy, and b

WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to the Company’s Board of Directors, effective immediately. The appointments bring together two accomplished leaders whose complementary experience spans public service, Medicare Advantage, clinical practice, healthcare policy, and b

Central banks are talking about higher interest rates for longer, and the OECD expects global inflation to linger. Cash in a savings account may feel safer, but it can struggle to keep up with rising prices. That is why some investors are looking at lower priced, financially robust smaller stocks as a way to stay in the game. This article highlights 3 such penny stocks for investors to examine more closely. The three penny stocks in this article are only a small sample, and the full screen...

A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at reforming prior authorization and payment rules in Medicare Advantage plans.

The Medicare Advantage insurer had already faced skepticism after its second-quarter report. Tuesday’s comments reinforced that picture.

Clover Health Investments (NASDAQ:CLOV) grew its share price by 8.53 percent on Thursday to finish at $4.71 apiece, as investors took heart from Deutsche Bank’s optimistic rating for its stock. In its initial coverage of the stock, the investment firm assigned a buy recommendation on shares of Clover Health Investments (NASDAQ:CLOV) alongside a price target […]

Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 8.5% in the afternoon session after Deutsche Bank initiated coverage on the company with a Buy rating and a $6.00 price target.

Global services sectors are still growing, and employment is holding up in many major economies, even as costs remain a concern. That mix of resilience and pressure keeps investors hunting for lower priced stocks that still have enough cash to fund their plans. This article highlights three cash backed penny stocks from our premium low price screener that aim to give you early stage exposure with fewer balance sheet red flags. The stocks in the list below are just a starting sample, and the...

On August 5, Clover Health Investments Corp. (NASDAQ:CLOV) reported second-quarter 2026 results that turned a year-ago loss into real profit. GAAP net income came in at $28 million, a $39 million swing from the $10.6 million loss posted in the same quarter last year. Medicare Advantage membership climbed to 157,309, up 48% year over year, […]

WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following investor conferences: Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Jefferies Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at 1:40 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investo

Germany’s 10 year bond yield is near levels last seen in 2011, which shows how firmly markets are pricing in higher-for-longer interest rates. Higher yields often pressure richly valued large caps. That shifts more attention toward Financially Fit Penny Stocks, where entry prices are lower and balance sheets play a larger role. This article highlights three stocks from the screener that combine penny stock pricing with a focus on financial health. The three Financially Fit Penny Stocks in...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 28.9% gain over the past six months, beating the S&P 500 by 18 percentage points.

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.

Let’s dig into the relative performance of Clover Health (NASDAQ:CLOV) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.